new pediatric hypertension CPG contains several modifications from the previous guideline to guide clinicians in diagnosis and management of elevated BP and hypertension in children and adolescents. This summary describes those changes made since the 2004 Fourth Report.
The childhood BP database used to develop normative BP data and BP tables in the previous pediatric BP CPGs included overweight and obese children. Recently, this BP database was reanalyzed by Rosner et al. 6 who found that when overweight and obese children were excluded the BP levels, adjusted for sex, age, and height, were 2 to 3 mm Hg lower than the values in the Fourth Report. Due to the strong association of excess adiposity with higher BP throughout childhood, it was determined that normative reference data and BP tables should reported LVH among some prehypertensive pediatric patients, 11 and an independent effect of obesity on cardiac mass, 12 and different approaches to quantifying cardiac mass. These There is strong evidence in support of antihypertensive therapy in adult hypertensive patients for the purpose of primary prevention of subsequent cardiovascular events. Similar evidence in pediatric hypertensive patients is lacking. Therefore, a major emphasis has been, and continues to be, on non-pharmacologic, or lifestyle changes in diet, physical activity, and M a n u s c r i p t Disclosures: None M a n u s c r i p t
